BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15254739)

  • 1. The subunits of glutamate cysteine ligase enhance cisplatin resistance in human non-small cell lung cancer xenografts in vivo.
    Fujimori S; Abe Y; Nishi M; Hamamoto A; Inoue Y; Ohnishi Y; Nishime C; Matsumoto H; Yamazaki H; Kijima H; Ueyama Y; Inoue H; Nakamura M
    Int J Oncol; 2004 Aug; 25(2):413-8. PubMed ID: 15254739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The modifier subunit of glutamate cysteine ligase relates to cisplatin resistance in human small cell lung cancer xenografts in vivo.
    Nishi M; Abe Y; Fujimori S; Hamamoto A; Inoue Y; Miyazaki N; Oida Y; Ikoma N; Ohnishi Y; Yamazaki H; Ueyama Y; Nakamura M
    Oncol Rep; 2005 Aug; 14(2):421-4. PubMed ID: 16012725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The modifier subunit of glutamate cysteine ligase (GCLM) is a molecular target for amelioration of cisplatin resistance in lung cancer.
    Inoue Y; Tomisawa M; Yamazaki H; Abe Y; Suemizu H; Tsukamoto H; Tomii Y; Kawamura M; Kijima H; Hatanaka H; Ueyama Y; Nakamura M; Kobayashi K
    Int J Oncol; 2003 Nov; 23(5):1333-9. PubMed ID: 14532974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
    Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts.
    Némati F; Daniel C; Arvelo F; Legrier ME; Froget B; Livartowski A; Assayag F; Bourgeois Y; Poupon MF; Decaudin D
    Anticancer Drugs; 2010 Jan; 21(1):25-32. PubMed ID: 19823076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin regulation of glutamate cysteine ligase catalytic and modifier subunit expression in rat ovary is subunit and follicle stage specific.
    Tsai-Turton M; Luderer U
    Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E391-402. PubMed ID: 15811874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy?
    Merk J; Rolff J; Dorn C; Leschber G; Fichtner I
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):e29-33. PubMed ID: 21420313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockout of the mouse glutamate cysteine ligase catalytic subunit (Gclc) gene: embryonic lethal when homozygous, and proposed model for moderate glutathione deficiency when heterozygous.
    Dalton TP; Dieter MZ; Yang Y; Shertzer HG; Nebert DW
    Biochem Biophys Res Commun; 2000 Dec; 279(2):324-9. PubMed ID: 11118286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit.
    Lavoie S; Chen Y; Dalton TP; Gysin R; Cuénod M; Steullet P; Do KQ
    J Neurochem; 2009 Mar; 108(6):1410-22. PubMed ID: 19183254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of constitutive signal transducer and activator of transcription 3 mRNA in cisplatin-resistant human non-small cell lung cancer cells.
    Ikuta K; Takemura K; Kihara M; Nishimura M; Ueda N; Naito S; Lee E; Shimizu E; Yamauchi A
    Oncol Rep; 2005 Feb; 13(2):217-22. PubMed ID: 15643501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and analysis of Ancylostoma ceylanicum glutamate-cysteine ligase.
    Wiśniewski M; Lapiński M; Zdziarska A; Długosz E; Bąska P
    Mol Biochem Parasitol; 2014 Aug; 196(1):12-20. PubMed ID: 25092620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an E-box motif as a transcriptional repressor element in the proximal promoter region of the GCLC gene in rat lung epithelial L2 cells.
    Cheng LL; Li B; Luo JD; Tu HB; Liu QC; Ran P
    Free Radic Biol Med; 2005 Oct; 39(8):1030-40. PubMed ID: 16198230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of glutamate-cysteine ligase during mouse development.
    Díaz D; Krejsa CM; Kavanagh TJ
    Mol Reprod Dev; 2002 May; 62(1):83-91. PubMed ID: 11933164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway.
    Liu LZ; Zhou XD; Qian G; Shi X; Fang J; Jiang BH
    Cancer Res; 2007 Jul; 67(13):6325-32. PubMed ID: 17616691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between the catalytic and modifier subunits of glutamate-cysteine ligase.
    Yang Y; Chen Y; Johansson E; Schneider SN; Shertzer HG; Nebert DW; Dalton TP
    Biochem Pharmacol; 2007 Jul; 74(2):372-81. PubMed ID: 17517378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts.
    Nakagawa T; Inoue Y; Kodama H; Yamazaki H; Kawai K; Suemizu H; Masuda R; Iwazaki M; Yamada S; Ueyama Y; Inoue H; Nakamura M
    Oncol Rep; 2008 Aug; 20(2):265-70. PubMed ID: 18636185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of glutathione synthesis in macrophages by oxidized low-density lipoproteins is mediated by consensus antioxidant response elements.
    Bea F; Hudson FN; Chait A; Kavanagh TJ; Rosenfeld ME
    Circ Res; 2003 Mar; 92(4):386-93. PubMed ID: 12600891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of 6-(methylsulfinyl)hexyl isothiocyanate for sensitization of tumor cells to antitumor agents in combination therapies.
    Yamaguchi H; Kidachi Y; Kamiie K; Noshita T; Umetsu H; Fuke Y; Ryoyama K
    Biochem Pharmacol; 2013 Aug; 86(4):458-68. PubMed ID: 23791871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate-cysteine ligase attenuates TNF-induced mitochondrial injury and apoptosis.
    Botta D; Franklin CC; White CC; Krejsa CM; Dabrowski MJ; Pierce RH; Fausto N; Kavanagh TJ
    Free Radic Biol Med; 2004 Sep; 37(5):632-42. PubMed ID: 15288121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.